ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Forearm Vascular Relaxation

This study is ongoing, but not recruiting participants.

Sponsored by: National Institute on Aging (NIA)
Information provided by: National Institute on Aging (NIA)
ClinicalTrials.gov Identifier: NCT00182923
  Purpose

The purpose of this study is to learn the effect of inherited differences on forearm blood flow responses to hormones and drugs


Condition
Healthy

U.S. FDA Resources

Study Type:   Observational
Study Design:   Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title:   Determinants of Forearm Vascular Relaxation: Role of Genetic Polymorphisms

Further study details as provided by National Institute on Aging (NIA):

Estimated Enrollment:   400
Study Start Date:   May 2003
Estimated Study Completion Date:   April 2005

Detailed Description:

Differences in at least 4 genes are believed to have an important effect on responses to hormones and drugs. For this study, healthy volunteers of normal body weight will be screened to find xxx individuals with the genes of interest. Very small doses of hormones and drugs will be given so that changes in forearm blood flow can be measured, while not causing effects throughout the body. A brachial artery line and venous line will be placed in the study arm so that blood samples may be withdrawn to compare amounts given into the artery and coming out of the vein after circulating through the arm. Forearm blood flow is determined by the rate of swelling of the arm after a blood pressure cuff is inflated (above venous and below arterial blood pressure). The hormones and drugs being studied include angiotensin I, angiotensin II, acetylcholine, sodium nitroprusside, enalaprilat, L-arginine, phenylephrine, endothelin-1, verapamil, and isoproterenol. This procedure will last 4-6 hours. The process will be repeated with the same participant over 2 weeks later.

  Eligibility
Ages Eligible for Study:   21 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Normal physical status without any medical interventions or agents which would alter the defined status of normal

Exclusion Criteria:

  • Age less than 21 or greater than 45
  • Unable to give informed consent
  • BMI (Body Mass Index) less than 18 or greater than 25
  • Clinically significant abnormal laboratory values
  • Abnormal physical exam
  • Abnormal EKG
  • Pregnancy
  • Smoking or drug usage (illicit or otherwise)
  • Post-menopause
  • Participation in another clinical trial in the past month
  • Chronic Illness
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00182923

Locations
United States, Maryland
National Institute on Aging (NIA), Harbor Hospital    
      Baltimore, Maryland, United States, 21225

Sponsors and Collaborators

Investigators
Principal Investigator:     Darrell R. Abernethy, MD, PhD     National Institute on Aging, Laboratory of Clinical Investigation    
  More Information

National Institute on Aging  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   AG0038
First Received:   September 12, 2005
Last Updated:   November 9, 2006
ClinicalTrials.gov Identifier:   NCT00182923
Health Authority:   United States: Federal Government

Keywords provided by National Institute on Aging (NIA):
Blood pressure  
genetics  

Study placed in the following topic categories:
Healthy

ClinicalTrials.gov processed this record on July 18, 2008




Links to all studies - primarily for crawlers